Launch of new CiToxLAB group
Group president foresees greater client benefits by leveraging the group services and resources
CiToxLAB launched with the announcement of the new name and logo for the company. The newly established group, created through the merger of CIT and LAB Research, provides a comprehensive range of pre-clinical and specialty services from four facilities in France, Canada, Denmark and Hungary. With combined revenues in excess of USD 100 million, and over 800 employees, the new group becomes a major global player in the preclinical outsourcing arena.
The company has launched the new name and logo in order to symbolize the combination of expertise, values, traditions and histories of the four laboratories. CIT in bold blue refers to the 40 years that CIT has provided CRO services to the pharmaceutical and related industries. The bold red of LAB represents the dynamic Montreal based company with numerous specialty activities.
“We are confident that this merger will make CiToxLAB an even more attractive partner for our traditional pharmaceutical and biotech clients,” stated Jean-Francois Le Bigot, president of the group. “We can offer all the benefits of local, smart-sized facilities, backed up by global resources. Our individual facilities can offer flexibility, direct contact to scientists and easy access to management. In addition, the resources of the group allow us to offer a wider range of services, aggressive scheduling and a broader geographic spread in the clients that we can reach and interact with.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
